Clinical improvement was noted in all horses involved in the clinical trial , but the group that received PUFA had greater improvement in clinical signs ( cough score improved @ % ) , lung function ( respiratory effort decreased @ % ) , and BALF ( neutrophils decreased from @ to @ % ) when compared to placebo ( cough score improved @ % , respiratory effort decreased @ % , BALF neutrophils increased from @ to @ % ; P < @ ) .